WCN26-5144 EFFICACY OF A NOVEL LDL APHERESIS DEVICE RHEOCARNA IN DIALYSIS PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA

Read full text Summarise with VIRAT
Authors: Kunihiro Ishioka, Takayasu Ohtake, Kei Ohmori, Chika Shibuya, Tomoki Tsukarahara, Mizuki Yamano, Yasuhiro Mochida, Machiko Oka, Kyoko Maesato, Yusuke Tsukamoto, Hidekazu Moriya, Sumi Hidaka
+1 more Shuzo Kobayashi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Lesions of lower extremity arterial disease (LEAD) in dialysis patients are frequently found in the more distal parts of the lower extremities. Therefore, the therapeutic effect of revascularization of the major arteries of the lower extremities alone is limited. Even with the current advances in revascularization technology, the prognosis of dialysis patients who have developed comprehensive severe chronic limb-threatening ischemia (CLTI) remains unsatisfactory, even after revascularization treatment.

Fields of Study & Subjects

Peripheral Artery Disease Management Dialysis and Renal Disease Management Lipoproteins and Cardiovascular Health

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105259–105259
Publication date
25 March 2026
Language
EN